ABSTRACT
Calcium phosphate cement has been widely investigated as a bone graft substitute due to its excellent self-setting ability, biocompatibility, osteoconductivity and moldability. In addition, mesoporous materials have been studied as potential materials for application in medical devices due to their large surface area, which is capable of loading numerous biological molecules, besides being bioactive. In this study, bone ß-TCP-MCPM-based injectable cement with mesoporous silica particles was synthesized and characterized in terms of its mechanical properties, microstructure, porosity, injectability, in vitro bioactivity and degradability; together with toxicity effects in CHO-K1 cell culture. The results showed that the ß-TCP-MCPM cement is bioactive after soaking in simulated body fluid solution, and mesoporous silica particles provided better physicochemical properties compared with silica-free cement. Toxicity assays showed low CHO-K1 cell viability after treatment with more concentrated extracts (200 mg ml-1). However, this behavior did not compromise the reproductive capacity and did not promote significant DNA damage in those cells. In conclusion, the ß-TCP-MCPM cement associated with mesoporous silica might be considered as a potential bone substitute for the repair and regeneration of bone defects.
Subject(s)
Bone Cements/chemistry , Bone Regeneration/drug effects , Bone Substitutes/chemistry , Calcium Phosphates/chemistry , Silicon Dioxide/chemistry , Animals , Body Fluids , Bone Cements/toxicity , CHO Cells , Comet Assay , Cricetinae , Cricetulus , DNA Damage , Injections , Materials Testing , Micronucleus Tests , Porosity , Regeneration , Stress, MechanicalABSTRACT
The aim of this work was the preparation of inorganic mesoporous materials from silica, calcium phosphate and a nonionic surfactant and to evaluate the incorporation and release of different concentrations of osteogenic growth peptide (OGP) for application in bone regeneration. The adsorption and release of the labeled peptide with 5,6-carboxyfluorescein (OGP-CF) from the mesoporous matrix was monitored by fluorescence spectroscopy. The specific surface area was 880 and 484 m(2) g(-1) for pure silica (SiO) and silica/apatite (SiCaP), respectively; the area influenced the percentage of incorporation of the peptide. The release of OGP-CF from the materials in simulated body fluid (SBF) was dependent on the composition of the particles, the amount of incorporated peptide and the degradation of the material. The release of 50% of the peptide content occurred at around 4 and 30 h for SiCaP and SiO, respectively. In conclusion, the materials based on SiO and SiCaP showed in vitro bioactivity and degradation; thus, these materials should be considered as alternative biomaterials for bone regeneration.
Subject(s)
Apatites/chemistry , Drug Carriers/chemistry , Histones/pharmacology , Intercellular Signaling Peptides and Proteins/pharmacology , Nanostructures/chemistry , Silicon Dioxide/chemistry , Adsorption , Body Fluids/drug effects , Fluoresceins/chemistry , Humans , Kinetics , Microscopy, Electron, Transmission , Nitrogen , Porosity , Scattering, Small Angle , Solutions , Spectroscopy, Fourier Transform Infrared , X-Ray DiffractionABSTRACT
The aim of this study was to develop and to evaluate the biological properties of bacterial cellulose-hydroxyapatite (BC-HA) nanocomposite membranes for bone regeneration. Nanocomposites were prepared from bacterial cellulose membranes sequentially incubated in solutions of CaCl(2) followed by Na(2)HPO(4). BC-HA membranes were evaluated in noncritical bone defects in rat tibiae at 1, 4, and 16 weeks. Thermogravimetric analyses showed that the amount of the mineral phase was 40%-50% of the total weight. Spectroscopy, electronic microscopy/energy dispersive X-ray analyses, and X-ray diffraction showed formation of HA crystals on BC nanofibres. Low crystallinity HA crystals presented Ca/P a molar ratio of 1.5 (calcium-deficient HA), similar to physiological bone. Fourier transformed infrared spectroscopy analysis showed bands assigned to phosphate and carbonate ions. In vivo tests showed no inflammatory reaction after 1 week. After 4 weeks, defects were observed to be completely filled in by new bone tissue. The BC-HA membranes were effective for bone regeneration.
ABSTRACT
Bacterial DNA gyrase, has been identified as the target of several antibacterial agents, including the coumarin drugs. The coumarins inhibit the gyrase action by competitive binding to the ATP-binding site of DNA gyrase B (GyrB) protein. The high in vitro inhibitory potency of coumarins against DNA gyrase reactions has raised interest in studies on coumarin-gyrase interactions. In this context, a series of low-molecular weight peptides, including the coumarin resistance-determining region of subunit B of Escherichia coli gyrase, has been designed and synthesized. The first peptide model was built using the natural fragment 131-146 of GyrB and was able to bind to novobiocin (K(a) = 1.8 +/- 0.2 x 10(5)/m) and ATP (K(a) = 1.9 +/- 0.4 x 10(3)/m). To build the other sequences, changes in the Arg(136) residue were introduced so that the binding to the drug was progressively reduced with the hydrophobicity of this residue (K(a) = 1.3 +/- 0.1 x 10(5)/m and 1.0 +/- 0.2 x 10(5)/m for Ser and His, respectively). No binding was observed for the change Arg(136) to Leu. In contrast, the binding to ATP was not altered, independently of the changes promoted. On the contrary, for peptide-coumarin and peptide-ATP complexes, Mg(2+) appears to modulate the binding process. Our results demonstrate the crucial role of Arg(136) residue for the stability of coumarin-gyrase complex as well as suggest a different binding site for ATP and in both cases the interactions are mediated by magnesium ions.
Subject(s)
Coumarins/metabolism , DNA Gyrase/metabolism , Adenosine Triphosphate/metabolism , Amino Acid Sequence , Arginine/metabolism , Binding Sites , Binding, Competitive , Chromatography, Affinity , Coumarins/chemistry , DNA Gyrase/chemistry , Drug Design , Escherichia coli Proteins , Magnesium/chemistry , Magnesium/metabolism , Molecular Sequence Data , Novobiocin/chemistry , Novobiocin/metabolism , Peptide Fragments/metabolismABSTRACT
Angiotensin II (AngII) and bradykinin (BK) derivatives containing the TOAC (2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid) spin label were synthesized by solid phase methodology. Ammonium hydroxide (pH 10, 50 degrees C, l h) was the best means for reverting nitroxide protonation occurring during peptide cleavage. EPR spectra yielded rotational correlation times for internally labeled analogs that were nearly twice as large as those of N-terminally labeled analogs. Except for TOAC(1)-AngII and TOAC(0)-BK, which showed high intrinsic activities, other derivatives were inactive in smooth muscle preparations. These active paramagnetic analogs may be useful for conformational studies in solution and in the presence of model and biological membranes.
Subject(s)
Angiotensins/chemistry , Bradykinin/chemistry , Cyclic N-Oxides/pharmacology , Muscle, Smooth/cytology , Nitric Oxide/chemistry , Spin Labels , Ammonium Hydroxide , Animals , Aorta/metabolism , Biological Assay , Bradykinin/analogs & derivatives , Dose-Response Relationship, Drug , Electron Spin Resonance Spectroscopy , Female , Guinea Pigs , Hydroxides/pharmacology , Ileum/metabolism , Male , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Peptide Biosynthesis , Peptides/chemistry , Protein Conformation , Rabbits , Rats , Time Factors , Uterus/metabolismABSTRACT
The stable free radical 2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid (TOAC) is the only spin labeled amino acid that has been used to date to successfully label peptide sequences for structural studies. However, severe difficulty in coupling the subsequent amino acid has been the most serious shortcoming of this paramagnetic marker. This problem stems from the low nucleophilicity of TOAC's amine group towards the acylation reaction during peptide chain elongation. The present report introduces the alternative beta-amino acid 2,2,5,5-tetramethylpyrrolidine-N-oxyl-3-amino-4-carboxylic acid (POAC), potentially useful in peptide and protein chemistry. Investigations aimed at addressing the stereochemistry of this cyclic molecule through X-ray diffraction measurements of crystalline and bulk samples revealed that it consists only of the trans conformer. The 9-fluorenylmethyloxycarbonyl group (Fmoc) was chosen for temporary protection of the POAC amine function, allowing insertion of the probe at any position in a peptide sequence. The vasoactive octapeptide angiotensin II (All, DRVYIHPF) was synthesized by replacing Pro7 with POAC. The reaction of Fmoc-POAC with the peptidyl-resin occurred smoothly, and the coupling of the subsequent amino acid showed a much faster reaction when compared with TOAC. POAC7-AII was obtained in good yield, demonstrating that, in addition to TOAC, POAC is a convenient amino acid for the synthesis of spin labeled peptide analogues. The present findings open the possibility of a wide range of chemical and biological applications for this novel beta-amino acid derivative, including structural investigations involving its differentiated bend-inducing characteristics.
Subject(s)
Amino Acids/chemistry , Cyclic N-Oxides/chemistry , Peptides/chemistry , Proteins/chemistry , Spin Labels/chemical synthesisABSTRACT
Quinolones constitute a family of compounds with a potent antibiotic activity. The enzyme DNA gyrase, responsible for the replication and transcription processes in DNA of bacteria, is involved in the mechanism of action of these drugs. In this sense, it is believed that quinolones stabilize the so-called 'cleavable complex' formed by DNA and gyrase, but the whole process is still far from being understood at the molecular level. This information is crucial in order to design new biological active products. As an approach to the problem, we have designed and synthesized low molecular weight peptide mimics of DNA gyrase. These peptides correspond to sequences of the subunit A of the enzyme from Escherichia coli, that include the quinolone resistance-determining region (positions 75-92) and a segment containing the catalytic Tyr-122 (positions 116-130). The peptide mimic of the non-mutated enzyme binds to ciprofloxin (CFX) only when DNA and Mg2+ were present (Kd = 1.6 x 10(-6) M), a result previously found with DNA gyrase. On the other hand, binding was reduced when mutations of Ser-83 to Leu-83 and Asp-87 to Asn-87 were introduced, a double change previously found in the subunit A of DNA gyrase from several CFX-resistant clinical isolates of E. coli. These results suggest that synthetic peptides designed in a similar way to that described here can be used as mimics of gyrases (topoisomerases) in order to study the binding of the quinolone to the enzyme-DNA complex as well as the mechanism of action of these antibiotics.
Subject(s)
Anti-Infective Agents/pharmacology , Escherichia coli/chemistry , Binding Sites , Chromatography, Affinity , Ciprofloxacin/antagonists & inhibitors , DNA Topoisomerases, Type II/biosynthesis , Drug Design , Escherichia coli/enzymology , Molecular Probes , Mutation , Peptides/therapeutic use , Spectrometry, Fluorescence , Topoisomerase II InhibitorsABSTRACT
A survey on the practices related to the management of patients with indwelling urinary catheter was organised in two hospitals and health districts, with the aim of identifying problems or incorrect habits. Thirty-five nurses were interviewed with a questionnaire exploring different practices and procedures related to the catheter care. While practices were overall satisfactory and homogeneous across wards, few problems were identified: the ill defined practice of bladder training before catheter removal; the difficulties in maintaining a closed system; an improper use of sterile sacs. The data were presented and discussed during two meetings attended by 186 nurses where the emerging problems and the practicability of changes in habits and ward protocols were thoroughly discussed.
Subject(s)
Urinary Catheterization/nursing , Humans , Italy , Surveys and Questionnaires , Urinary BladderABSTRACT
A case of intestinal haemorrhage due to ectopic ulcerated gastric mucosa in Meckel's diverticulum in a young male is reported. The haemorrhage was stopped 5 days after continuous infusion with ranitidine (6 fials in 500 cc of physiological solution X 2). The therapy also proved effective in cases of bleeding ectopic gastric mucosa.
Subject(s)
Hemorrhage/drug therapy , Ileal Diseases/drug therapy , Meckel Diverticulum/surgery , Ranitidine/therapeutic use , Adolescent , Hemorrhage/etiology , Humans , Ileal Diseases/etiology , Infusions, Intravenous , Male , Meckel Diverticulum/complications , Ranitidine/administration & dosageABSTRACT
The technique of liver arterialization with the left gastric artery after portocaval shunt in the rat is described. The operation was carried out with three different modalities, and the best results were obtained when suturing was carried out after enlargement of the arterial caliber (0.4-0.5 mm external diameter), advantage of a vessel bifurcation. Eighty percent of the anastomosis were patent without any anticoagulant treatment 1 month after surgery. Preliminary results show the positive effect of liver arterialization compared to treatment with portocaval shunt alone.